Scientists demonstrate the role of a protein called ADAMTS1 in rare eye cancer

Virus surge pushes Spain regions to tighten curbs
15 January 2021
How we got to two million COVID-19 deaths
15 January 2021

Scientists demonstrate the role of a protein called ADAMTS1 in rare eye cancer

Scientists from the University of Granada and GENYO (Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research), in a study led by Juan Carlos Rodríguez-Manzaneque, have demonstrated the significant role of a protein called ADAMTS1 in uveal melanoma, one of the rarest and most aggressive cancers that exist, which develops in the eye.

Comments are closed.